Search





Search





Markets
/
Stocks
/
nasdaq-htfl
/

Heartflow Inc

HTFL

Add to Watchlist

28.315USD

-3.925-12.17%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

2.44BMarket Cap

LossP/E TTM



Heartflow Inc

28.315

-3.925-12.17%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

More Details of Heartflow Inc Company

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc Info



Ticker SymbolHTFL

Company nameHeartflow Inc

IPO dateAug 08, 2025

CEOFarquhar (John C. M)

Number of employees699

Security typeOrdinary Share

Fiscal year-endAug 08

Address331 E Evelyn Avenue

CityMOUNTAIN VIEW

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code94041

Phone16502411221

Websitehttps://www.heartflow.com/

Ticker SymbolHTFL

IPO dateAug 08, 2025

CEOFarquhar (John C. M)

Company Executives of Heartflow Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Casey M. Tansey

Independent Director

3.19M

+99.48%

Mr. Jeffrey C. Lightcap

Independent Director

246.26K

Mr. Vikram Verghese

Chief Financial Officer

130.21K

-1.54%

Mr. Lonnie M. Smith

Independent Director

34.25K

Dr. Charles A. Taylor, Ph.D.

Director

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Mr. John C. M. Farquhar

President, Chief Executive Officer, Director

Ms. Julie Cullivan

Independent Director

Mr. Tim Barabe

Independent Director

Dr. Wayne Riley, M.D.

Independent Director

Name

Name/Position

Position

Shareholding

Change

Mr. Casey M. Tansey

Independent Director

3.19M

+99.48%

Mr. Jeffrey C. Lightcap

Independent Director

246.26K

Mr. Vikram Verghese

Chief Financial Officer

130.21K

-1.54%

Mr. Lonnie M. Smith

Independent Director

34.25K

Dr. Charles A. Taylor, Ph.D.

Director

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2024

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United states

162.73M

92.44%

Rest of the world

13.30M

7.56%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Thu, May 14

Shareholders

Shareholder Types

Shareholders

Proportion

Wellington Management Company, LLP

13.82%

Bain Capital Life Sciences Investors, LLC

9.80%

Fidelity Management & Research Company LLC

4.66%

Tansey (Casey M)

3.70%

Baron Capital Management, Inc.

2.67%

Other

65.35%

Shareholders

Proportion

Wellington Management Company, LLP

13.82%

Bain Capital Life Sciences Investors, LLC

9.80%

Fidelity Management & Research Company LLC

4.66%

Tansey (Casey M)

3.70%

Baron Capital Management, Inc.

2.67%

Other

65.35%

Shareholder Types

Shareholders

Proportion

Investment Advisor

41.91%

Investment Advisor/Hedge Fund

23.87%

Individual Investor

5.19%

Hedge Fund

4.55%

Research Firm

0.31%

Bank and Trust

0.30%

Venture Capital

0.18%

Pension Fund

0.09%

Private Equity

0.04%

Other

23.55%

Institutional Shareholding



Updated: Wed, Apr 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q4

129

59.51M

43.48%

2026Q1

237

65.02M

75.47%

+2.36M

2025Q4

157

60.44M

71.29%

+22.15M

2025Q3

45.42M

54.46%

+42.91M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Wellington Management Company, LLP

11.92M

13.9%

+6.03M

+102.26%

Feb 27, 2026

Bain Capital Life Sciences Investors, LLC

10.45M

12.18%

-2.00M

-16.07%

Feb 04, 2026

Fidelity Management & Research Company LLC

4.02M

4.69%

-598.27K

-12.95%

Dec 31, 2025

Baron Capital Management, Inc.

2.30M

2.69%

+1.07M

+86.17%

Dec 31, 2025

HealthCor Partners Management LP

6.70M

7.81%

Dec 31, 2025

Schusterman Interests LLC

1.94M

2.26%

Dec 31, 2025

Capricorn Investment Group LLC

1.66M

1.94%

-2.26M

-57.64%

Dec 31, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

TrueShares Technology, AI & Deep Learning ETF

3.13%

Global X HealthTech ETF

1.75%

Fidelity Blue Chip Growth ETF

0.07%

T Rowe Price Small-Mid Cap ETF

0.06%

iShares Health Innovation Active ETF

0.02%

Schwab U.S. Small-Cap ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Schwab U.S. Broad Market ETF

TrueShares Technology, AI & Deep Learning ETF

Proportion3.13%

Global X HealthTech ETF

Proportion1.75%

Fidelity Blue Chip Growth ETF

Proportion0.07%

T Rowe Price Small-Mid Cap ETF

Proportion0.06%

iShares Health Innovation Active ETF

Proportion0.02%

Schwab U.S. Small-Cap ETF

Proportion0.02%

Fidelity Nasdaq Composite Index ETF

Proportion0.01%

Schwab U.S. Broad Market ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data

KeyAI

